LON:BELL Belluscura (BELL) Share Price, News & Analysis → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free BELL Stock Alerts GBX 7.64 -0.11 (-1.42%) (As of 06:07 AM ET) Add Compare Share Share Today's Range 7.08▼ 8.4950-Day Range 7.25▼ 25.8852-Week Range 7▼ 52Volume75,616 shsAverage Volume390,165 shsMarket Capitalization£12.56 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsStock AnalysisChartCompetitors Get Belluscura alerts: Email Address Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. About BelluscuraBelluscura plc develops and commercialize oxygen related medical device products. The company offers X-PLOR, a modular portable oxygen concentrator. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.Read More BELL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BELL Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive BELL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Belluscura and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolLON:BELL CUSIPN/A CIKN/A Webwww.belluscura.com PhoneN/AFaxN/AEmployees24Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-10,000,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-40.83% Return on Assets-18.19% Debt Debt-to-Equity Ratio0.44 Current Ratio8.89 Quick Ratio5.13 Sales & Book Value Annual Sales£1.20 million Price / Sales10.47 Cash FlowGBX 0.96 per share Price / Cash Flow8.00 Book ValueGBX 19 per share Price / Book0.40Miscellaneous Outstanding Shares164,380,000Free FloatN/AMarket Cap£12.56 million OptionableNot Optionable Beta0.71 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Robert Rauker (Age 59)CEO & Director Comp: $461.77kMr. Simon Neicheril (Age 65)CFO & Director Mr. Keith CookVice President of OperationsMr. Robert Fary (Age 66)Senior Vice President of Global Sales & Executive Director Mr. Jim ClementHead of Commercial StrategyKey CompetitorsAdvanced OncotherapyLON:AVOPolarean ImagingLON:POLXRUA Life SciencesLON:RUAMyHealthCheckedLON:MHCSurgical Innovations GroupLON:SUNView All Competitors BELL Stock Analysis - Frequently Asked Questions How have BELL shares performed in 2024? Belluscura's stock was trading at GBX 23 at the beginning of 2024. Since then, BELL shares have decreased by 66.8% and is now trading at GBX 7.64. View the best growth stocks for 2024 here. How do I buy shares of Belluscura? Shares of BELL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:BELL) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Belluscura plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.